We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.11%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.25B
AUM Growth
+$233M
Cap. Flow
+$71.7M
Cap. Flow %
2.21%
Top 10 Hldgs %
43.43%
Holding
357
New
26
Increased
176
Reduced
122
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLAD icon
326
Gladstone Capital
GLAD
$430M
$177K 0.01%
8,257
+191
+2% +$4.01K
CRF
327
Cornerstone Total Return Fund
CRF
$1.15B
$170K 0.01%
23,051
+1,310
+6% +$9.26K
TRIN icon
328
Trinity Capital Inc.
TRIN
$1.6B
$164K 0.01%
11,183
+368
+3% +$5.31K
TCPC icon
329
BlackRock TCP Capital
TCPC
$283M
$154K ﹤0.01%
14,786
+512
+4% +$5.66K
CLM icon
330
Cornerstone Strategic Value Fund
CLM
$2.2B
$154K ﹤0.01%
20,829
+1,229
+6% +$8.76K
HRTX icon
331
Heron Therapeutics
HRTX
$96.8M
$130K ﹤0.01%
46,970
-893
-2% -$2.25K
VLY icon
332
Valley National Bancorp
VLY
$8.02B
$115K ﹤0.01%
14,500
NAK
333
Northern Dynasty Minerals
NAK
$818M
$95.1K ﹤0.01%
298,950
-20,000
-6% -$5.51K
MRSN
334
DELISTED
Mersana Therapeutics
MRSN
$68.8K ﹤0.01%
614
-12
-2% -$1.19K
IBRX icon
335
ImmunityBio
IBRX
$7.49B
$53.7K ﹤0.01%
10,000
FLG
336
Flagstar Bank National Association
FLG
$5.93B
$44.5K ﹤0.01%
4,607
+32
+0.7% +$592
EOSE icon
337
Eos Energy Enterprises
EOSE
$1.36B
$41.2K ﹤0.01%
40,000
REKR icon
338
Rekor Systems
REKR
$90M
$37.8K ﹤0.01%
16,500
VOR icon
339
Vor Biopharma
VOR
$1.16B
$33.5K ﹤0.01%
706
+23
+3% +$1.01K
RBBN icon
340
Ribbon Communications
RBBN
$373M
$32.1K ﹤0.01%
10,030
RGLS
341
DELISTED
Regulus Therapeutics
RGLS
$29.6K ﹤0.01%
10,264
-156
-1% -$254
XFOR icon
342
X4 Pharmaceuticals
XFOR
$386M
$20.9K ﹤0.01%
500
AKBA icon
343
Akebia Therapeutics
AKBA
$351M
$18.3K ﹤0.01%
+10,000
New +$16K
FUBO icon
344
FuboTV Inc
FUBO
$283M
$15.8K ﹤0.01%
833
ISPC icon
345
iSpecimen
ISPC
$2.89M
$7.15K ﹤0.01%
39
AMT icon
346
American Tower
AMT
$80.6B
-959
Closed -$207K
CIEN icon
347
Ciena
CIEN
$55.3B
-4,893
Closed -$220K
GLO
348
Clough Global Opportunities Fund
GLO
$252M
-50,367
Closed -$237K
IAI icon
349
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
-47,909
Closed -$5.2M
IGV icon
350
iShares Expanded Tech-Software Sector ETF
IGV
$13.8B
-2,625
Closed -$213K

Similar funds

Grimes & Company's Q1 2024 Portfolio in Review

As of Q1 2024, Grimes & Company held 357 positions worth $3.25B, up 7.7% from $3.02B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Grimes & Company's Q1 2024 filing shows 26 new, 176 increased, 122 reduced and 12 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 352,196 shares worth $14.8M. The largest sale was State Street Energy Select Sector SPDR ETF, an estimated $17.9M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q1 2024 buy was State Street Financial Select Sector SPDR ETF: 352,196 shares worth $14.8M.
  • Grimes & Company added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2024, an estimated $27.8M increase.
  • Grimes & Company's biggest Q1 2024 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $17.9M.
  • Grimes & Company fully exited State Street SPDR S&P Biotech ETF in Q1 2024, selling an estimated $5.42M.
  • Grimes & Company's ten largest holdings make up 43% of its $3.25B portfolio in Q1 2024.
  • Grimes & Company opened 26 new positions and closed 12 in Q1 2024.
  • Grimes & Company's portfolio value rose 7.7% quarter-over-quarter to $3.25B.

Based on Grimes & Company's 13F filing for Q1 2024, filed 17 Apr 2024.